First Royal Care Co. LLC, dba Red Mountain S-MIC/B12(C)/CARNITINE 25/50/50/1/50MG/ML MDV INJ recall — FDA D-0274-2020
Lack of Assurance of Sterility
Complete FDA and NHTSA recall records dated in November 2019.
These records include useful source details for the selected month.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Marketed without an Approved NDA/ANDA
Marketed without an Approved NDA/ANDA
CGMP Deviations: Presence of NDMA impurity detected in product.
CGMP Deviations: Presence of NDMA impurity detected in product.
Marketed without an Approved NDA/ANDA
CGMP Deviations: Presence of NDMA impurity detected in product.
Marketed without an Approved NDA/ANDA
CGMP Deviations: Presence of NDMA impurity detected in product.
CGMP Deviations: Presence of NDMA impurity detected in product.
Presence of Foreign substance: identified as a dead ant.
Presence of Foreign substance: identified as a dead ant.
CGMP Deviations: Presence of NDMA impurity detected in product.
Presence of Foreign substance: identified as a dead ant.
Marketed without an Approved NDA/ANDA
Marketed without an Approved NDA/ANDA
Marketed without an Approved NDA/ANDA
CGMP Deviations: Presence of NDMA impurity detected in product.
Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
Marketed without an Approved NDA/ANDA
Marketed without an Approved NDA/ANDA
CGMP Deviations: Presence of NDMA impurity detected in product.
Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.